GlassScriptPhysician profile
Donna H Foster
NPI 1093717266
$6,160.40
in general payments reported to CMS, 2019-2025
18 companies · $2,548 in 2025
The $2,548 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $379 · 2024: $3,233 · 2025: $2,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,673 · Travel and Lodging: $2,463 · Education: $24.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,672.86 |
| Travel and Lodging | $2,462.69 |
| Education | $24.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,691.12 | 2023-2025 | Linq II, Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan |
| Abiomed | $2,110.16 | 2024-2025 | Impella |
| Abbott Laboratories | $494.54 | 2023-2025 | Jot Dx, Aveir, Merlin@Home |
| Kestra Medical Technology Services, INC. | $275.78 | 2024-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $167.87 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $87.17 | 2024-2025 | Enroute Transcarotid Neuroprotection System, Synergy, Cds - Mct/Cem Monitoring |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.37 | 2024-2025 | Lifevest |
| Ge Healthcare | $47.94 | 2024 | |
| Merck Sharp & Dohme LLC | $39.96 | 2024-2025 | Verquvo |
| Scpharmaceuticals INC. | $33.45 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.50 | 2023-2024 | Jardiance |
| Inari Medical, INC. | $27.41 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $24.79 | 2024 | Savvywire |
| Amgen INC. | $15.70 | 2024 | Repatha |
| Abbvie INC. | $15.41 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.04 | 2025 | Camzyos |
| Terumo Medical Corporation | $13.15 | 2024 | Metacross Otw, R2p Misago, Glidewire |
| Astrazeneca Pharmaceuticals LP | $13.04 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.